Iconic Brands, Inc.

$ Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000147793223004911 Filed on June 29, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q4

Balance Sheet

Concept	2023 Q1	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$212.6K	$916.5K
YoY Change	-97.2%	-58.16%
Cash & Equivalents	$212.6K	$916.5K
Short-Term Investments
Other Short-Term Assets	$545.6K	$550.5K
YoY Change	3.31%	638.7%
Inventory	$1.435M	$1.555M
Prepaid Expenses
Receivables	$1.058M	$1.302M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$3.252M	$4.324M
YoY Change	-78.79%	-0.51%
LONG-TERM ASSETS
Property, Plant & Equipment	$12.54M	$7.462M
YoY Change	71.54%	34.29%
Goodwill		$0.00
YoY Change		-100.0%
Intangibles	$1.009M	$1.085M
YoY Change	-95.15%	-94.98%
Long-Term Investments
YoY Change
Other Assets	$398.1K	$400.5K
YoY Change	77.89%	181.3%
Total Long-Term Assets	$13.95M	$14.03M
YoY Change	-72.0%	-69.73%
TOTAL ASSETS
Total Short-Term Assets	$3.252M	$4.324M
Total Long-Term Assets	$13.95M	$14.03M
Total Assets	$17.20M	$18.36M
YoY Change	-73.59%	-63.79%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$5.897M	$5.111M
YoY Change	74.73%	273.68%
Accrued Expenses	$2.454M	$2.211M
YoY Change	336.44%	481.06%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$5.162M
YoY Change	-100.0%	2.31%
Long-Term Debt Due	$5.618M
YoY Change
Total Short-Term Liabilities	$14.35M	$12.98M
YoY Change	16.39%	-22.05%
LONG-TERM LIABILITIES
Long-Term Debt	$229.7K	$262.8K
YoY Change	56.23%	78.75%
Other Long-Term Liabilities	$4.592M	$4.757M
YoY Change	-81.94%	-67.85%
Total Long-Term Liabilities	$4.822M	$5.019M
YoY Change	-81.15%	-66.41%
TOTAL LIABILITIES
Total Short-Term Liabilities	$14.35M	$12.98M
Total Long-Term Liabilities	$4.822M	$5.019M
Total Liabilities	$18.52M	$18.00M
YoY Change	-51.14%	-43.03%
SHAREHOLDERS EQUITY
Retained Earnings	-$73.68M	-$70.99M
YoY Change		92.07%
Common Stock	$107.6K	$107.3K
YoY Change	10.82%	18.48%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$1.317M	$360.2K
YoY Change
Total Liabilities & Shareholders Equity	$17.20M	$18.36M
YoY Change	-73.59%	-63.79%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q4

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001350073
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	107276138	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	107596138	shares
CY2022Q1	icnb	Net Of Forfeitures NetOfForfeitures	280798	usd
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	000-53162
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	ICONIC BRANDS, INC.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	13-4362274
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	44 Seabro Avenue
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Amityville
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	11701
CY2023Q1	dei	City Area Code CityAreaCode	631
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	464-4050
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	107936138	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	212622	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	916526	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1058337	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1302175	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	1435057	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	1554693	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	545572	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	550482	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	3251588	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	4323876	usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	4921695	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	5086989	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7621465	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7462219	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1009488	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1085200	usd
CY2023Q1	us-gaap	Other Assets OtherAssets	398084	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	400464	usd
CY2023Q1	us-gaap	Assets Assets	17202320	usd
CY2022Q4	us-gaap	Assets Assets	18358748	usd
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	7670136	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	6912440	usd
CY2023Q1	us-gaap	Notes Payable Current NotesPayableCurrent	5617701	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	5068915	usd
CY2023Q1	icnb	Factoring Liability Current FactoringLiabilityCurrent	0	usd
CY2022Q4	icnb	Factoring Liability Current FactoringLiabilityCurrent	93249	usd
CY2023Q1	us-gaap	Deferred Revenue DeferredRevenue	336102	usd
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	189195	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	45000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	45000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	680454	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	670288	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	14349393	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	12979087	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4591923	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4756660	usd
CY2023Q1	us-gaap	Long Term Notes Payable LongTermNotesPayable	229663	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	262759	usd
CY2023Q1	us-gaap	Liabilities Liabilities	19170979	usd
CY2022Q4	us-gaap	Liabilities Liabilities	17998506	usd
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	38	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	38	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	107596138	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	107276138	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	107597	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	107277	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	72250010	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	72045951	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-73675071	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-70992412	usd
CY2023Q1	us-gaap	Minority Interest MinorityInterest	-651233	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	-800612	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1968659	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	360242	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	17202320	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	18358748	usd
CY2023Q1	us-gaap	Revenues Revenues	2014919	usd
CY2022Q1	us-gaap	Revenues Revenues	4046797	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1124123	usd
CY2022Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2205039	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	890796	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	1841758	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3174814	usd
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4458387	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	110762	usd
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	351977	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	3285576	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	4810364	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2394780	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2968606	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	171040	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	183134	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	32540	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-138500	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-183134	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2533280	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-3151740	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	149379	usd
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-93819	usd
CY2023Q1	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-2682659	usd
CY2022Q1	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-3057921	usd
CY2023Q1	icnb	Basic And Diluted Loss Per Common Share BasicAndDilutedLossPerCommonShare	-0.03
CY2022Q1	icnb	Basic And Diluted Loss Per Common Share BasicAndDilutedLossPerCommonShare	-0.03
CY2023Q1	icnb	Weighted Average Number Of Shares Outstanding Basic And Diluted WeightedAverageNumberOfSharesOutstandingBasicAndDiluted	107301027	shares
CY2022Q1	icnb	Weighted Average Number Of Shares Outstanding Basic And Diluted WeightedAverageNumberOfSharesOutstandingBasicAndDiluted	94923294	shares
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	19113055	usd
CY2022Q1	icnb	Common Stock And Series A2 Preferred Stock Issued For Cash Net Of Fees Amount CommonStockAndSeriesA2PreferredStockIssuedForCashNetOfFeesAmount	10998076	usd
CY2022Q1	icnb	Conversion Of Series A2 Preferred Stock For Common Stock Amount ConversionOfSeriesA2PreferredStockForCommonStockAmount	0	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	280798	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-3151740	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	27240189	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	360242	usd
CY2023Q1	icnb	Conversion Of Series A2 Preferred Stock For Common Stock Amount ConversionOfSeriesA2PreferredStockForCommonStockAmount	0	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	204379	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2533280	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1968659	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2533280	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-3151740	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	240366	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	78348	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	165294	usd
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	201253	usd
CY2023Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	45312	usd
CY2022Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	679141	usd
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	47000	usd
CY2023Q1	icnb	Provision For Excess And Obsolete Inventory ProvisionForExcessAndObsoleteInventory	40000	usd
CY2022Q1	icnb	Provision For Excess And Obsolete Inventory ProvisionForExcessAndObsoleteInventory	0	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	75712	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	796600	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	204379	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	280798	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	435303	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3224755	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-79636	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1953368	usd
CY2023Q1	icnb	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-154571	usd
CY2022Q1	icnb	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-45904	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	757696	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1769095	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	4910	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-453554	usd
CY2023Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	2380	usd
CY2022Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-81417	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	146907	usd
CY2022Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	10660	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-681421	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5726984	usd
CY2023Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	399612	usd
CY2022Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	1833396	usd
CY2023Q1	icnb	Common Stock And Series A2 Preferred Stock Issued For Cash Net Of Fees CommonStockAndSeriesA2PreferredStockIssuedForCashNetOfFees	0	usd
CY2022Q1	icnb	Common Stock And Series A2 Preferred Stock Issued For Cash Net Of Fees CommonStockAndSeriesA2PreferredStockIssuedForCashNetOfFees	10998076	usd
CY2023Q1	icnb	Net Proceeds From Factoring Arrangement NetProceedsFromFactoringArrangement	0	usd
CY2022Q1	icnb	Net Proceeds From Factoring Arrangement NetProceedsFromFactoringArrangement	1960604	usd
CY2023Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	500000	usd
CY2022Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	usd
CY2023Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	93249	usd
CY2022Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	usd
CY2023Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	29622	usd
CY2022Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	377129	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	12958680	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-703904	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	5398300	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	916526	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2190814	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	212622	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7589114	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	2273	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	0	usd
CY2022Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	2617474	usd
CY2023Q1	icnb	Conversion Of Series A2 Preferred Stock For Common Stock ConversionOfSeriesA2PreferredStockForCommonStock	320	usd
CY2022Q1	icnb	Conversion Of Series A2 Preferred Stock For Common Stock ConversionOfSeriesA2PreferredStockForCommonStock	2242	usd
CY2023Q1	us-gaap	Nature Of Operations NatureOfOperations	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>1. ORGANIZATION AND NATURE OF BUSINESS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Iconic Brands, Inc., (“the Company”, or “Iconic”), was incorporated in the State of Nevada on October 21, 2005. As of June 30, 2022, the subsidiaries of Iconic are wholly-owned TopPop LLC (“TopPop”) and United Spirits Inc., (“United”), 54% owned BiVi LLC (“BiVi”) and Bellissima Spirits LLC (“Bellissima”) and 60% owned Empire Wine and Spirits LLC (“Empire”) which was organized on February 4, 2022.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">BiVi is the brand owner of “BiVi 100 percent Sicilian Vodka,” and Bellissima is the brand owner of Bellissima sparkling wines. BiVi was organized in Nevada on May 4, 2015. Bellissima was organized in Nevada on November 23, 2015.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On July 26, 2021, the Company acquired 100% of TopPop. TopPop is organized as a limited liability company in the State of New Jersey on September 5, 2019. TopPop’s primary operation is the manufacture and packaging of alcohol and non-alcohol single-serve, shelf-stable, ready-to-freeze ice pops. TopPop began operations in December 2019 (see note 3). On July 26, 2021, the company purchased all the outstanding stock of United.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Empire was organized in the State of Nevada on February 4, 2022. Since its formation, there has been no business activity or transactions. </p>
CY2023Q1	icnb	Working Capital Deficiency WorkingCapitalDeficiency	11097805	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-73675071	usd
CY2023Q2	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt	1450000	usd
CY2023Q2	us-gaap	Cash Cash	359000	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.</p>
CY2023Q1	us-gaap	Proceeds Accounts Receivable Previously Written Off Recovery ProceedsAccountsReceivablePreviouslyWrittenOffRecovery	679141	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	68000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	747141	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	204379	usd
CY2023Q1	icnb	Net Of Forfeitures NetOfForfeitures	95093	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	280798	usd
CY2023Q1	icnb	Potentially Dilutive Shares PotentiallyDilutiveShares	94962016	shares
CY2022Q1	icnb	Potentially Dilutive Shares PotentiallyDilutiveShares	25620245	shares
CY2023Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	5599267	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	5599267	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	4589779	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	4514067	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1009488	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1085200	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	75712	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	796600	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	227134	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	302847	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	302847	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	176660	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1009488	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	8774365	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	8374753	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1152900	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	912534	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7621465	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7462219	usd
CY2023Q1	us-gaap	Depreciation Depreciation	240366	usd
CY2022Q1	us-gaap	Depreciation Depreciation	78348	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	1435057	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	1554693	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	5699259	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5111079	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	676195	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	676195	usd
CY2023Q1	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	141334	usd
CY2022Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	138796	usd
CY2023Q1	us-gaap	Accrued Sales Commission Current And Noncurrent AccruedSalesCommissionCurrentAndNoncurrent	197645	usd
CY2022Q4	us-gaap	Accrued Sales Commission Current And Noncurrent AccruedSalesCommissionCurrentAndNoncurrent	204132	usd
CY2023Q1	icnb	Accrued Interest Current AccruedInterestCurrent	845828	usd
CY2022Q4	icnb	Accrued Interest Current AccruedInterestCurrent	725601	usd
CY2023Q1	icnb	Other Accounts Payable Liabilities Current OtherAccountsPayableLiabilitiesCurrent	109875	usd
CY2022Q4	icnb	Other Accounts Payable Liabilities Current OtherAccountsPayableLiabilitiesCurrent	56637	usd
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	7670136	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	6912440	usd
CY2022Q4	us-gaap	Notes Payable NotesPayable	5331674	usd
CY2023Q1	icnb	Issuances Of Principal Net IssuancesOfPrincipalNet	550000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	-4688	usd
CY2023Q1	icnb	Payments Toward Promissory Note PaymentsTowardPromissoryNote	-29622	usd
CY2023Q1	us-gaap	Notes Payable NotesPayable	5847364	usd
CY2023Q1	icnb	Notes Payable Description NotesPayableDescription	Holders of approximately $3.55 million of these notes have agreed to extend the term until December 1, 2022, and have indicated that they will not seek cash settlement prior to August 2023
CY2023Q1	icnb	Notes Payable Due One Year Or Less NotesPayableDueOneYearOrLess	5609959	usd
CY2023Q1	icnb	Notes Payable Due One To Two Years NotesPayableDueOneToTwoYears	32077	usd
CY2023Q1	icnb	Notes Payable Due Two To Three Years NotesPayableDueTwoToThreeYears	35204	usd
CY2023Q1	icnb	Notes Payable Due Three To Four Years NotesPayableDueThreeToFourYears	32543	usd
CY2023Q1	icnb	Notes Payable Due Four To Five Years NotesPayableDueFourToFiveYears	3617	usd
CY2023Q1	icnb	Notes Payable Due Five Years Or More NotesPayableDueFiveYearsOrMore	133964	usd
CY2023Q1	us-gaap	Notes Payable NotesPayable	5847364	usd
CY2023Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	0	usd
CY2022Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	93249	usd
CY2023Q1	us-gaap	Debt Instrument Increase Accrued Interest DebtInstrumentIncreaseAccruedInterest	0	usd
CY2022	us-gaap	Debt Instrument Increase Accrued Interest DebtInstrumentIncreaseAccruedInterest	2273	usd
CY2022Q1	icnb	Preferred Stock Shares Sold PreferredStockSharesSold	12258	shares
CY2022Q1	icnb	Preferred Stock Shares Designated PreferredStockSharesDesignated	4301004	shares
CY2022Q1	icnb	Warrants Issued To Purchase Shares Of Common Stock WarrantsIssuedToPurchaseSharesOfCommonStock	40018583	shares
CY2022Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	12200000	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	10900000	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	879348	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	1201600	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	1235886	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	1271201	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	1248889	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	325461	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive	1099614	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	7261999	usd
CY2023Q1	icnb	Imputed Interest ImputedInterest	1989622	usd
CY2023Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	5272377	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	5272377	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	5426948	usd
CY2023Q1	us-gaap	Subordinated Borrowing Interest Rate SubordinatedBorrowingInterestRate	0.10	pure
CY2023Q1	icnb	Weighted Average Remaining Lease Term WeightedAverageRemainingLeaseTerm	P4Y10M20D
CY2023Q1	us-gaap	Occupancy Net OccupancyNet	320801	usd
CY2022Q1	us-gaap	Occupancy Net OccupancyNet	450138	usd
CY2023Q1	us-gaap	Revenues Revenues	2014919	usd
CY2022Q1	us-gaap	Revenues Revenues	4046797	usd
CY2019Q3	us-gaap	Investment Company Fee Waiver Terms InvestmentCompanyFeeWaiverTerms	the Company executed a Commission Agreement with CAA-GBA USA, LLC (“CAA-GBG”). The agreement provides CAA-GBG to receive 5% revenue generated with respect to the co-packing or related manufacturing deal for Anheuser-Busch, LLC. Additionally, CAA-GBG is also entitled to receive 5% of revenue for new business identified. The initial agreement expired on July 31, 2021 and automatically renews every year. No commissions were incurred under this agreement since the date of acquisition of TopPop (July 26, 2021) through March 31, 2023. On May 23, 2022,CAA-GBG received notice of termination and the Commission Agreement ended on July 31, 2022
CY2023Q1	icnb	Consulting Expenses ConsultingExpenses	27600	usd
CY2022Q1	icnb	Consulting Expenses ConsultingExpenses	45000	usd
CY2023Q1	us-gaap	Assets Assets	17202320	usd
CY2023Q1	us-gaap	Liabilities Liabilities	19170979	usd
CY2022Q4	us-gaap	Assets Assets	18358748	usd
CY2022Q4	us-gaap	Liabilities Liabilities	17998506	usd
CY2023Q1	us-gaap	Revenues Revenues	2014919	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	1124123	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	3285576	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2394780	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	171040	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	240366	usd
CY2022Q1	us-gaap	Revenues Revenues	4046797	usd
CY2022Q1	us-gaap	Costs And Expenses CostsAndExpenses	2205039	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	4810364	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2968606	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	183134	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	78348	usd
CY2023Q1	icnb	Short Term Debt Principal Amount ShortTermDebtPrincipalAmount	550000	usd
CY2023Q1	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2023-04-03
CY2023Q1	us-gaap	Debt Default Longterm Debt Amount DebtDefaultLongtermDebtAmount	564918	usd
CY2023Q1	us-gaap	Preferred Stock Convertible Conversion Price Decrease PreferredStockConvertibleConversionPriceDecrease	0.0001
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q2	icnb	Aggregate Principal Amount AggregatePrincipalAmount	17446000	usd
CY2023Q2	us-gaap	Short Term Debt Interest Rate Increase ShortTermDebtInterestRateIncrease	0.12	pure
CY2023Q2	us-gaap	Preferred Stock Convertible Conversion Price Decrease PreferredStockConvertibleConversionPriceDecrease	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	17446000	usd

Files In Submission

Name	View Source	Status
0001477932-23-004911-index-headers.html	Edgar Link	pending
0001477932-23-004911-index.html	Edgar Link	pending
0001477932-23-004911.txt	Edgar Link	pending
0001477932-23-004911-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
icnb-20230331.xsd	Edgar Link	pending
icnb_10q.htm	Edgar Link	pending
icnb_10qimg2.jpg	Edgar Link	pending
icnb_ex311.htm	Edgar Link	pending
icnb_ex321.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
icnb-20230331_def.xml	Edgar Link	unprocessable
icnb-20230331_lab.xml	Edgar Link	unprocessable
icnb-20230331_pre.xml	Edgar Link	unprocessable
icnb_10q_htm.xml	Edgar Link	completed
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
icnb-20230331_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

Iconic Brands, Inc.

2023 Q2 Form 10-Q Financial Statement

#000147793223004911 Filed on June 29, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission